Repositorio Institucional
Repositorio Institucional
CONICET Digital
  • Inicio
  • EXPLORAR
    • AUTORES
    • DISCIPLINAS
    • COMUNIDADES
  • Estadísticas
  • Novedades
    • Noticias
    • Boletines
  • Ayuda
    • General
    • Datos de investigación
  • Acerca de
    • CONICET Digital
    • Equipo
    • Red Federal
  • Contacto
JavaScript is disabled for your browser. Some features of this site may not work without it.
  • INFORMACIÓN GENERAL
  • RESUMEN
  • ESTADISTICAS
 
Artículo

Antimicrobial Resistance of Uropathogenic Escherichia coli from Elderly Patients at a General Hospital, Argentina

Delpech, GastónIcon ; Garcia Allende, Natalia; Lissarrague, Sabina; Sparo, Mónica Delfina
Fecha de publicación: 07/2018
Editorial: Bentham Open
Revista: The Open Infectious Diseases Journal
ISSN: 1874-2793
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:
Enfermedades Infecciosas

Resumen

Background:Urinary Tract Infection (UTI) is a common cause of morbidity and mortality in older adults.Objective:To investigate antimicrobial resistance of uropathogenic Escherichia coli from elderly patients in a General Hospital, Argentina.Method:During the period July 2011-July 2015, patients over 70 years old with urinary tract infections, without urinary catheters and with noantimicrobial therapy the previous week before sampling, were included. Phenotypic characterization was carried out. In vitroqualitative and quantitative antimicrobial resistances were investigated. Antimicrobials assayed: ampicillin, amoxicillin-clavulanate,cefazolin, cefuroxime, cefoxitin, cefotaxime, ceftazidime, cefepime, imipenem, ertapenem, gentamicin, nalidixic acid, ciprofloxacin,trimethoprim-sulfamethoxazole (TMS) and nitrofurantoin. Patients? medical records were produced, and risk factors were analyzedby multivariate analysis.Results:768 bacterial isolates were identified as E. coli. Resistances to ampicillin (80.5%), nalidixic acid (61.7%), ciprofloxacin (42.8%),TMS (37.6%), amoxicillin-clavulanate (28.6%), cefazolin (21.6%), cefuroxime (20.7%), gentamicin (13.8%), cefotaxime (9.7%),ceftazidime (9.7%), cefepime (8.4%), cefoxitin (3.1%) and nitrofurantoin (2.3%) were observed. Resistance to carbapenems was notexpressed. Production of extended spectrum β-lactamases was detected (7.6%) in community acquired (96%) and healthcareassociated (4%) isolates. The independent risk factors for urinary infections produced by multi-resistant E. coli were: diabetesmellitus, recurrent infections, hospitalization during the last year and exposure to β-lactams in the last 3 months. Conclusion:A high prevalence of resistance to β-lactams and to other antimicrobials was observed. Detection of antimicrobial multi-resistantisolates highlights the need of antimicrobial resistance surveillance in elderly patients with urinary tract infections.
Palabras clave: BETA LACTAMASES , ELDERLY PATIENTS , ESCHERICHIA COLI , INFECTION , RESISTANCE , URINARY TRACT
Ver el registro completo
 
Archivos asociados
Thumbnail
 
Tamaño: 244.3Kb
Formato: PDF
.
Descargar
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/92653
URL: https://openinfectiousdiseasesjournal.com/VOLUME/10/PAGE/79/
DOI: http://dx.doi.org/10.2174/1874279301810010079
Colecciones
Articulos(CIVETAN)
Articulos de CENTRO DE INVESTIGACION VETERINARIA DE TANDIL
Citación
Delpech, Gastón; Garcia Allende, Natalia; Lissarrague, Sabina; Sparo, Mónica Delfina; Antimicrobial Resistance of Uropathogenic Escherichia coli from Elderly Patients at a General Hospital, Argentina; Bentham Open; The Open Infectious Diseases Journal; 10; 7-2018; 79-87
Compartir
Altmétricas
 

Enviar por e-mail
Separar cada destinatario (hasta 5) con punto y coma.
  • Facebook
  • X Conicet Digital
  • Instagram
  • YouTube
  • Sound Cloud
  • LinkedIn

Los contenidos del CONICET están licenciados bajo Creative Commons Reconocimiento 2.5 Argentina License

https://www.conicet.gov.ar/ - CONICET

Inicio

Explorar

  • Autores
  • Disciplinas
  • Comunidades

Estadísticas

Novedades

  • Noticias
  • Boletines

Ayuda

Acerca de

  • CONICET Digital
  • Equipo
  • Red Federal

Contacto

Godoy Cruz 2290 (C1425FQB) CABA – República Argentina – Tel: +5411 4899-5400 repositorio@conicet.gov.ar
TÉRMINOS Y CONDICIONES